...
首页> 外文期刊>BMC Pulmonary Medicine >Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: a case report and review of literature
【24h】

Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: a case report and review of literature

机译:先进进展性差异化的非小细胞肺癌的自发缓解:一个案例报告和文学审查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Spontaneous remission (SR) of cancer is a very rare phenomenon of unknown mechanism. In particular, SR of non-small cell lung cancer (NSCLC) has been scarcely reported. We present the case of a 74-year-old woman with advanced, poorly differentiated NSCLC (highly expressing programmed death ligand-1 [PD-L1]) that progressed despite multiple lines of chemotherapy but then spontaneously remitted.CASE PRESENTATION:The patient presented with hemoptysis and was diagnosed with stage IIIA poorly differentiated NSCLC via bronchoscopic biopsy. She had an unremarkable medical history and moderate performance status. The initial treatment plan was surgery after neoadjuvant chemotherapy. Despite conventional chemotherapy, follow-up chest computed tomography (CT) showed gradual tumor progression and she decided against further treatment after fifth-line chemotherapy. However, the size of lung mass was markedly decreased on follow-up chest CT one year after ceasing chemotherapy. Also, follow-up positron emission tomography images showed decreased metabolic activity in the lung mass and a percutaneous biopsy specimen from the diminished lung mass revealed no viable tumor cells. A diagnosis of SR of NSCLC was confirmed, and the patient was without tumor progression on follow-up nine months later. Later, PD-L1 immunostaining revealed high positivity (?99%) in initial tumor cells.CONCLUSION:Our case showing SR of poorly advanced NSCLC refractory to multiple lines of chemotherapy suggested the association between immunity and tumor regression.
机译:背景:癌症的自发缓解(SR)是未知机制的非常罕见的现象。特别地,几乎没有报道非小细胞肺癌(NSCLC)的SR。我们展示了一个74岁女性的先进,差异化的NSCLC(高度表达编程死亡配体-1 [PD-L1]),尽管有多条化疗,但随后自发地汇总了.Case介绍:患者呈现通过咯血,被诊断为IIIA期通过支气管镜活组织检查患有阶段差异的NSCLC。她有一个不起眼的病史和适度的绩效状况。初始治疗计划在新辅助化疗后进行手术。尽管常规化疗,随访胸部计算断层扫描(CT)显示逐渐肿瘤进展,并在第五线化疗后反对进一步治疗。然而,在停止化疗后,肺部质量的大小明显降低,随访胸部CT一年内显着降低。此外,随访正电子发射断层摄影图像显示出肺部质量的代谢活性降低,并且来自肺部质量减少的经皮活组织检查标本显示出没有可行的肿瘤细胞。确认了NSCLC SR的诊断,患者在后续九个月后没有肿瘤进展。后来,PD-L1免疫染色在初始肿瘤细胞中揭示了高阳性(> 99%)。结论:我们的案例显示出多种化疗的多条化疗的难以达到的高级NSCLC耐火材料的案例表明免疫和肿瘤回归之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号